**Author details**

Iva Christova National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria

\*Address all correspondence to: iva\_christova@yahoo.com

© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**101**

*Vector-Borne Infections in Bulgaria*

[1] Liang FT, Philipp MT. Epitope mapping of the immunodominant invariable region of *Borrelia burgdorferi* VlsE in three host species. Infection and

Immunity. 2000;**68**:2349-2352

[2] McDowell JV, Sung S, Hu LT, Marconi RT. Evidence that the variable regions of the central domain of VlsE are antigenic during infection with Lyme disease spirochetes. Infection and

Immunity. 2002;**70**:4196-4203

[3] Christova I, Trifonova I, Gladnishka T, Taseva E, Ivanova V, Rusimova D. C6 peptides from *Borrelia burgdorferi* sensu stricto, *Borrelia afzelii* and *Borrelia garinii* as antigens for serological diagnosis of Lyme borreliosis. Biotechnology & Biotechnological Equipment. 2014;**27**:3540-3542

[4] Christova I, Schous L, van De Pol I, Park J, Panayotov S, Lefterova V, et al. High prevalence of granulocytic Ehrlichiae and *Borrelia burgdorferi* sensu lato in *Ixodes ricinus* ticks from Bulgaria. Journal of Clinical Microbiology.

[5] Balmelli T, Piffaretti JC. Association

[6] Schouls L, van de Pol I, Rijpkema S, Schot C. Detection and identification of Ehrlichia, *Borrelia burgdorferi* sensu lato, and Bartonella species in Dutch *Ixodes ricinus* ticks. Journal of Clinical Microbiology. 1999;**37**:2215-2222

[7] Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M. Crimean-Congo hemorrhagic

pathogenesis, clinical syndrome and genetic diversity. Antiviral Research.

fever: History, epidemiology,

2013;**100**:159-189

manifestations of Lyme disease and different species of *Borrelia burgdorferi* sensu lato. Research in Microbiology.

2002;**39**:4172-4174

1995;**146**:329-340

between different clinical

**References**

*DOI: http://dx.doi.org/10.5772/intechopen.81916*

[8] Mardani M, Keshtkar-Jahromi M. Crimean–Congo hemorrhagic fever. Archives of Iranian Medicine.

[9] Pshenichnaya NY, Nenadskaya SA. Probable Crimean-Congo hemorrhagic fever virus transmission occurred after aerosol-generating medical procedures

in Russia: Nosocomial cluster. International Journal of Infectious

[10] Midilli K, Gargili A, Ergonul O, Elevli M, Ergin S, Turan N, et al. The first clinical case due to AP92 like strain of Crimean–Congo hemorrhagic fever virus and a field survey. BMC Infectious

[11] Salehi-Vaziri M, Baniasadi V, Jalali T, Mirghiasi SM, Azad-Manjiri S, Zarandi R, et al. The first fatal case of Crimean-Congo hemorrhagic fever due to AP92 like strain of Crimean-Congo hemorrhagic fever virus.

Japanese Journal of Infectious Diseases.

[12] Nekliudov M. A case of hemorrhagic fever (Crimean). Savremenna Med.

[13] Papa A, Pappa S, Panayotova E, Papadopoulou E, Christova I. Molecular epidemiology of Crimean-Congo hemorrhagic fever in Bulgaria—An update. Journal of Medical Virology.

[14] Christova I, Panayotova E, Trifonova I, Taseva E, Hristova T, Ivanova V. Country-wide seroprevalence studies on Crimean-Congo hemorrhagic fever and hantavirus infections in general population of Bulgaria. Journal of Medical Virology. 2017;**89**:1720-1725

[15] Sidira P, Maltezou HC, Haidich AB, Papa A. Seroepidemiological study of Crimean-Congo haemorrhagic

Diseases. 2015;**33**:120-122

Diseases. 2009;**9**:90

2016;**69**:344-346

1952;**5**:92-95

2016;**88**:769-773

2007;**10**:204-214

*Vector-Borne Infections in Bulgaria DOI: http://dx.doi.org/10.5772/intechopen.81916*
